Navigation Links
Doctor Evidence, LLC Closes 2012 With Strong Sales Growth
Date:6/14/2013

Santa Monica, CA (PRWEB) June 14, 2013

Doctor Evidence, LLC continued its multiple-year trend of sustained growth with sales bookings increased over 163% year-over-year from 2011 to 2012. Revenue growth represented an increase of 100% in the same period.

Doctor Evidence’s 2012 success can be attributed both to the expansion of existing projects as well as the start of new initiatives with a varied list of clients, including academic groups, provider networks, managed care organizations, and nine of the top ten medical manufacturers (life science and device).

Among 2012 achievements was the continued collaboration between Doctor Evidence and distinguished healthcare organizations—such as Kaiser Permanente—on the development of the Guidelines Consortium, which enlists the capabilities of the Doctor Evidence product suite to create and share evidence-backed guidelines with colleagues all over the world. A wider rollout is planned for Q3 2013, with several large and prominent healthcare transformation systems joining the Doctor Evidence Guideline Consortium Network. The Guideline Consortium Network will be featured to a global audience of stakeholders at the upcoming Guidelines International Network (GIN) Conference in San Francisco, California in August 2013.

The past year also saw the launch and refinement of Doctor Evidence’s groundbreaking DOC™ Label product, which enables clients in the regulatory affairs and labeling departments of institutions to save, search, and compare over 23,000 prescription drug labels and label versions from the FDA in minutes rather than the hours or even days a more traditional search would require.

About Doctor Evidence, LLC

Doctor Evidence is a specialty software platform and services company aimed to assist stakeholders across the healthcare ecosystem to make and inform clinical and business decisions with the most relevant medical evidence. The Doctor Evidence methodology uses a Digital Outcome Conversion (DOC™) approach of taking data from published clinical studies, FDA drug labels, and epidemiological databases to transform static data into reusable, dynamic relational databases. Our software platform empowers both public and private sector clients to identify the most relevant literature and conduct ready analyses with the highest level of transparency available for today's evidence-based medicine methodological standards in the pursuit of reducing healthcare costs while increasing the quality of patient outcomes.

Doctor Evidence serves decision makers in two large addressable market segments: Medical Manufacturers and Healthcare Providers for the ultimate wellbeing of patients. Doctor Evidence is helping to transform the healthcare ecosystem by identify the most efficacious and safe medical treatment on a comparative effectiveness basis, including related economic costs and total-cost-of-care analysis.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10818390.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Happy Father's Day From Dr. Bob, "The Drugless Doctor" Offering Noteworthy Health Tips
2. Innovative Approach to Healthcare through Telemedicine by Online USA Doctors
3. Just What the Doctor Ordered: GW MFA’s EpiCURE with Chef MDs Nabs National Telly Award
4. Medical Doctor Studies, Inc Announces Open House Meetings
5. Online USA Doctors Introduces a Convenient and Affordable Alternative to Office Visits with Primary Care Physicians
6. Online USA Doctors Launches New Telemedicine Based Healthcare Plans; an Affordable Alternative to Health Insurance
7. Reynolds grant supports aging education of doctors
8. Internationally Recognized Ayurvedic Doctor Akhilesh Sharma Visits Bogota, Colombia
9. Almost Half of Cancer Doctors Report Symptoms of Burnout: Survey
10. Corporate Whistle Blower Center Urges ER Doctors Or Hospital Staff To Turn In Hospitals That Are Needlessly Admitting Patients-For Huge Whistleblower Rewards
11. Fertility Solutions Welcomes a New Doctor, Dr. Vasiliki Moragianni
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... , ... The Case Management Society of America (CMSA) will install six new ... membership has elected their upcoming President-Elect, Secretary, Treasurer and two Directors to serve on ... Advisory position has also been added to the BOD, per an appointment made by ...
(Date:3/27/2017)... ... March 27, 2017 , ... EpiGentek ... to pursue the recent RNA methylation “gold rush” with their established portfolio of ... newfound characteristics of N6-methyladenosine, or m6A , RNA methylation has received a ...
(Date:3/27/2017)... Foothill Ranch, California (PRWEB) , ... March 27, 2017 , ... ... company’s commitment to its customers. First National Capital has added 10 new sales professionals ... to grow its sales positions by 15 additional new hires over the course of ...
(Date:3/27/2017)... RICHEY, Fla. (PRWEB) , ... March 27, 2017 ... ... drug overdose deaths soared 167%,(1) with opioids alone responsible for over 33,000 of ... Kevin McCarty has sponsored Assembly Bill (AB) 1512, which proposes a tax on ...
(Date:3/25/2017)... ... March 25, 2017 , ... Norland at Swissray is pleased to announce the ... subjects. The ELITE DXA has an active scan window, which is more than double ... fit in the scan area could not undergo an accurate total body bone density or ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... -- A new survey from the American Association ... Program (CBP) significantly reduced beneficiary choice and access to ... forces beneficiaries to switch to unfamiliar or unsuitable testing ... AADE,s survey is the latest in a continuous ... the inherent problems with the CBP. Last year, a ...
(Date:3/27/2017)... YORK , March 27, 2017 FinancialBuzz.com ... Based ... adult use in states where cannabis is legal will generate $655 ... million will be from cannabis specific taxes, such as ... $96 million will be earned from state sales taxes that are ...
(Date:3/27/2017)... BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... AGI-134, an immunotherapy for the treatment of multiple cancers, obtained ... featured at the upcoming American Association for Cancer Research ... to be held on April 1-5, 2017. ... An abstract titled ...
Breaking Medicine Technology: